However, the fact that differences occurred in inflammatory markers, such as IL-10, IL-17, and TNFa, in IBS-D but not in other IBS subtypes could lead to the suggestion that the molecular mechanisms underlying the IBS symptomatologies could be rather different. Here, IL17A is linked to irritable bowel syndrome.